Evidence map›Paper›PMID 36533156›Full record

ArticleDementia & neuropsychologia2022

Diagnosis and management of Parkinson's disease dementia and dementia with Lewy bodies: recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology.

Jacy Bezerra Parmera, Vitor Tumas, Henrique Ballalai Ferraz, Mariana Spitz, Maira Tonidandel Barbosa, Jerusa Smid, Breno José Alencar Pires Barbosa, Lucas Porcello Schilling, Márcio Luiz Figueiredo Balthazar, Leonardo Cruz de Souza and 8 more

Open access · diamondAbstract read
In one paragraph

Article in Dementia & neuropsychologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 1 country.

Jacy Bezerra ParmeraUniversidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Grupo de Neurologia Cognitiva e do Comportamento, São Paulo SP, Brasil.ORCID 0000-0002-3565-5328
Vitor TumasUniversidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Neurociências e Ciências do Comportamento, São Paulo SP, Brasil.ORCID 0000-0003-2402-2709
Henrique Ballalai FerrazUniversidade Federal de São Paulo, Escola Paulista de Medicina, Departamento de Neurologia e Neurocirurgia, São Paulo SP, Brasil.ORCID 0000-0002-3821-1407
Mariana SpitzUniversidade do Estado do Rio de Janeiro, Serviço de Neurologia, Rio de Janeiro RJ, Brasil.ORCID 0000-0001-7548-2313
Maira Tonidandel BarbosaUniversidade Federal de Minas Gerais, Faculdade de Medicina, Departamento de Medicina Interna, Belo Horizonte MG, Brasil.ORCID 0000-0001-7520-3476
Jerusa SmidUniversidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Grupo de Neurologia Cognitiva e do Comportamento, São Paulo SP, Brasil.ORCID 0000-0001-9513-0964
Breno José Alencar Pires BarbosaUniversidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Grupo de Neurologia Cognitiva e do Comportamento, São Paulo SP, Brasil.ORCID 0000-0003-4333-2024
Lucas Porcello SchillingPontifícia Universidade do Rio Grande do Sul, Escola de Medicina, Serviço de Neurologia, Porto Alegre RS, Brasil.ORCID 0000-0002-9923-6982
Márcio Luiz Figueiredo BalthazarUniversidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Neurologia, Campinas SP, Brasil.ORCID 0000-0002-4780-444X
Leonardo Cruz de SouzaUniversidade Federal de Minas Gerais, Departamento de Clínica Médica, Belo Horizonte MG, Brasil.ORCID 0000-0001-5027-9722
Francisco Assis Carvalho ValeUniversidade Federal de São Carlos, Centro de Ciências Biológicas e da Saúde, Departamento de Medicina, São Carlos SP, Brasil.ORCID 0000-0001-8826-2010
Paulo CaramelliUniversidade Federal de Minas Gerais, Departamento de Clínica Médica, Belo Horizonte MG, Brasil.ORCID 0000-0002-4786-6990
Paulo Henrique Ferreira BertolucciUniversidade Federal de São Paulo, Escola Paulista de Medicina, Departamento de Neurologia e Neurocirurgia, São Paulo SP, Brasil.ORCID 0000-0001-7902-7502
Márcia Lorena Fagundes ChavesHospital de Clínicas de Porto Alegre, Serviço de Neurologia, Porto Alegre RS, Brasil.ORCID 0000-0002-1940-4043
Sonia Maria Dozzi BruckiUniversidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Grupo de Neurologia Cognitiva e do Comportamento, São Paulo SP, Brasil.ORCID 0000-0002-8303-6732
Ricardo NitriniUniversidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Grupo de Neurologia Cognitiva e do Comportamento, São Paulo SP, Brasil.ORCID 0000-0002-5721-1525
Raphael Machado CastilhosHospital de Clínicas de Porto Alegre, Serviço de Neurologia, Porto Alegre RS, Brasil.ORCID 0000-0002-1905-2084
Norberto Anízio Ferreira FrotaHospital Geral de Fortaleza, Serviço de Neurologia, Fortaleza CE, Brasil.ORCID 0000-0002-2828-5664
Universidade de São Paulo · BRUniversidade Federal de Minas Gerais · BRUniversidade Federal de São Paulo · BRHospital de Clínicas de Porto Alegre · BRUniversidade de Fortaleza · BRUniversidade do Estado do Rio de Janeiro · BRUniversidade Estadual de Campinas (UNICAMP) · BRUniversidade Federal de São Carlos · BRUniversidade Federal do Rio Grande · BRUniversidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB) represent the second most common type of degenerative dementia in patients aged 65 years and older, leading to progressive cognitive dysfunction and impaired quality of life. This study aims to provide a consensus based on a systematic Brazilian literature review and a comprehensive international review concerning PDD and DLB. Moreover, we sought to report on and give recommendations about the best diagnostic approaches focusing on primary and secondary care. Based on the available data, we recommend clinicians to apply at least one brief global cognitive instrument to assess PDD, such as the Mini-Mental State Examination and preferably the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised. Validated instruments to accurately assess functional abilities in Brazilian PD patients are still incipient. Further studies should focus on biomarkers with Brazilian cohorts.

Indexed as

ConsensusDementiaLewy BodiesParkinson Disease

Identifiers

PMID36533156
PMCPMC9745997
OpenAlexW4312067485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.